Pfiz­er launch­es re­bate pro­gram for rare dis­ease pa­tients who have to stop tak­ing Panzy­ga

Pfiz­er is launch­ing its sec­ond-ever re­bate pro­gram, this time for Panzy­ga, its treat­ment for a rare neu­ro­log­i­cal dis­ease of the pe­riph­er­al nerves.

The pro­gram be­gan …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.